Bio-Path Holdings Inc (BPTH)
2.54
-0.10
(-3.61%)
USD |
NASDAQ |
Apr 26, 11:11
Bio-Path Holdings PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| August 28, 2007 | 89.83 |
| August 27, 2007 | 89.83 |
| August 24, 2007 | 89.83 |
| August 23, 2007 | 89.83 |
| August 22, 2007 | 89.83 |
| August 21, 2007 | 89.83 |
| August 20, 2007 | 89.83 |
| August 17, 2007 | 89.83 |
| August 16, 2007 | 89.83 |
| August 15, 2007 | 89.83 |
| August 14, 2007 | 89.83 |
| August 13, 2007 | 89.83 |
| August 10, 2007 | 89.83 |
| August 09, 2007 | 89.83 |
| August 08, 2007 | 89.83 |
| August 07, 2007 | 89.83 |
| August 06, 2007 | 62.88 |
| August 03, 2007 | 62.88 |
| August 02, 2007 | 62.88 |
| August 01, 2007 | 62.88 |
| July 31, 2007 | 62.88 |
| July 10, 2007 | 62.88 |
| July 09, 2007 | 62.88 |
| July 06, 2007 | 62.88 |
| July 05, 2007 | 62.88 |
| Date | Value |
|---|---|
| July 03, 2007 | 62.88 |
| July 02, 2007 | 62.88 |
| June 30, 2007 | 62.88 |
| June 29, 2007 | 23.58 |
| June 28, 2007 | 23.58 |
| June 27, 2007 | 23.58 |
| June 26, 2007 | 23.58 |
| June 25, 2007 | 23.58 |
| June 22, 2007 | 23.58 |
| June 21, 2007 | 23.58 |
| June 20, 2007 | 23.58 |
| June 19, 2007 | 23.58 |
| June 18, 2007 | 23.58 |
| June 15, 2007 | 23.58 |
| June 14, 2007 | 33.68 |
| June 13, 2007 | 33.68 |
| June 12, 2007 | 33.68 |
| June 11, 2007 | 33.68 |
| June 08, 2007 | 33.68 |
| June 07, 2007 | 33.68 |
| June 06, 2007 | 33.68 |
| June 05, 2007 | 33.68 |
| June 04, 2007 | 33.68 |
| April 11, 2007 | 41.09 |
| April 10, 2007 | 41.09 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PS Ratio Benchmarks
| EyePoint Pharmaceuticals Inc | 13.65 |
| INVO Bioscience Inc | 0.4515 |
| SINTX Technologies Inc | 0.1332 |
| Aileron Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.0302 |
PS Ratio Related Metrics
| Price to Book Value | 3.910 |
| Price | 2.54 |
| Earnings Yield | -1.36K% |
| Market Cap | 1.724M |